NCIRS Seminar Series

NCIRS Seminar Series 2017 #4 - Wednesday 26th July 2017 - 11am

Save the date for our next seminar to be held on Wednesday 26 July 2017 @11am
Topic TBC

NCIRS Seminar Series 2017 #3 - Maternal Immunisation against Pertussis: Latest evidence - Wednesday 24th May

Maternal vaccination in the third trimester of pregnancy is now the preferred strategy for protection of infants in the “immunity gap” between birth and three-months of age. This strategy was however implemented in the absence of evidence from clinical trials, and many questions about the details of its effects remain.  

In this seminar Prof. Peter McIntyre (Director, NCIRS) gave an overview of the background on maternal immunisation against pertussis and present some recent evidence from the UK and California. Dr Nathan Saul (Epidemiologist, Vaccine Preventable Diseases at NSW Health) presented breaking data on effectiveness from a NSW case-control study conducted by all public health units in 2015-16.

Video Resources: Coming soon


NCIRS Seminar Series 2017 #2 - All Creatures Great and Small: A One Health Approach to the Problem of Q Fever - Wednesday 22 March

Q fever, caused by Coxiella burnetii, is a serious zoonotic disease in humans with a worldwide distribution. Many species of animals are capable of transmitting C. burnetii, and consequently all veterinary workers are at risk for this disease. Australia is the only country to have a licensed Q fever vaccine (QVax ). This vaccine has been readily available and used in Australia for many years in at-risk groups, however still has 600 notifications across Australia annually.

This presentation provided an overview of the sources of Q fever in our animal populations, new data on longevity of immunity post vaccination, as well as information on the safety of the Q fever vaccine in young adults and barriers to uptake of the vaccine.

 Video Resources: Coming soon


NCIRS Seminar Series 2017 #1 - Pneumococcal vaccines for elderly adults - Wednesday 22 February

The first NCIRS seminar covered the internationally controversial area of pneumococcal vaccines for elderly adults. Persons over 65 have a progressively increasing incidence of pneumococcal invasive disease and pneumonia but both available vaccines have limitations. In Australia the PBAC has recommended, in principle, moving from 23 valent polysaccharide vaccine to 13 valent conjugate vaccine to prevent pneumonia.

Epidemiologists Prof. Robert Booy and Dr Sanjay Jayasinghe presented on the issues on Wednesday 22nd February

Video resources

1. Introduction by Prof. P. McIntyre and Talk 1: Pneumococcal disease epidemiology in the elderly & 13vPCV efficacy by Sanjay Jayasinghe


2. Talk 2: Comparing the effectiveness of polysaccharide pneumococcal vaccine in bacteremic and non-bacteremic pneumonia: Focus on pneumococcal pneumonia by Prof. Robert Booy


3. Questions & Discussion: Pneumococcal Vaccines for Elderly Adults